Rachid Malek

1.3k total citations
50 papers, 583 citations indexed

About

Rachid Malek is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Pharmacology. According to data from OpenAlex, Rachid Malek has authored 50 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Physiology and 6 papers in Pharmacology. Recurrent topics in Rachid Malek's work include Diabetes Management and Research (23 papers), Diabetes Treatment and Management (22 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers). Rachid Malek is often cited by papers focused on Diabetes Management and Research (23 papers), Diabetes Treatment and Management (22 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers). Rachid Malek collaborates with scholars based in Algeria, United Kingdom and United Arab Emirates. Rachid Malek's co-authors include León Litwak, Zanariah Hussein, Mohammad E. Khamseh, Su‐Yen Goh, Thomas H. Williams, Siddharth Shah, Ansar U. Khan, Ole Molskov Bech, Pradana Soewondo and А. В. Зилов and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Urology.

In The Last Decade

Rachid Malek

43 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachid Malek Algeria 11 375 147 68 66 60 50 583
Miho Senda Japan 8 206 0.5× 93 0.6× 83 1.2× 97 1.5× 67 1.1× 17 472
Weigang Zhao China 13 241 0.6× 85 0.6× 87 1.3× 137 2.1× 83 1.4× 55 547
MK Garg India 16 313 0.8× 87 0.6× 96 1.4× 70 1.1× 78 1.3× 39 585
Thijs T. W. van Herpt Netherlands 9 165 0.4× 99 0.7× 37 0.5× 72 1.1× 77 1.3× 17 465
Fatheya Alawadi United Arab Emirates 15 276 0.7× 253 1.7× 73 1.1× 49 0.7× 55 0.9× 56 596
Chidum E. Ezenwaka Trinidad and Tobago 14 296 0.8× 66 0.4× 49 0.7× 141 2.1× 25 0.4× 50 477
Margaret Tiktin United States 6 336 0.9× 52 0.4× 64 0.9× 49 0.7× 86 1.4× 7 480
Helen X. Gao 7 212 0.6× 49 0.3× 82 1.2× 56 0.8× 65 1.1× 14 429
Jiemin Pan China 16 255 0.7× 76 0.5× 146 2.1× 99 1.5× 83 1.4× 34 574
Andreas Liebl Germany 10 426 1.1× 55 0.4× 93 1.4× 64 1.0× 121 2.0× 17 509

Countries citing papers authored by Rachid Malek

Since Specialization
Citations

This map shows the geographic impact of Rachid Malek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachid Malek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachid Malek more than expected).

Fields of papers citing papers by Rachid Malek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachid Malek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachid Malek. The network helps show where Rachid Malek may publish in the future.

Co-authorship network of co-authors of Rachid Malek

This figure shows the co-authorship network connecting the top 25 collaborators of Rachid Malek. A scholar is included among the top collaborators of Rachid Malek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachid Malek. Rachid Malek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belhadj, M., et al.. (2025). Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review. Frontiers in Clinical Diabetes and Healthcare. 6. 1495849–1495849.
2.
Hassanein, Mohamed, et al.. (2024). Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis. Diabetes Therapy. 15(11). 2309–2322. 2 indexed citations
3.
Hassanein, Mohamed, Muhammad Yakoob Ahmedani, Inass Shaltout, et al.. (2023). Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global survey. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(7). 102799–102799. 4 indexed citations
4.
Ritzel, Robert, Sujoy Ghosh, Rıfat Emral, et al.. (2023). Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics. Diabetes Obesity and Metabolism. 25(9). 2495–2504. 3 indexed citations
5.
Hassanein, Mohamed, Rachid Malek, Inass Shaltout, et al.. (2023). Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(2). 102707–102707. 10 indexed citations
6.
Malek, Rachid, et al.. (2022). POSA38 Cost-Effectiveness Analysis of for Insulin Degludec (TRESIBA®) vs. Insulin Glargine U300 (TOUJEO®) in Algerian Setting. Value in Health. 25(1). S40–S40. 1 indexed citations
7.
Hafidh, Khadija, et al.. (2022). Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort. Frontiers in Endocrinology. 13. 940309–940309. 8 indexed citations
8.
9.
Malek, Rachid. (2021). Prevalence of type 2 diabetes mellitus in Africa: an updated narrative review. SHILAP Revista de lepidopterología. 4(9). S87–S92. 2 indexed citations
10.
Hassanein, Mohamed, Mehmet Akif Büyükbeşe, Rachid Malek, et al.. (2020). Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study. Diabetes Research and Clinical Practice. 166. 108189–108189. 28 indexed citations
11.
Mbanya, Jean Claude, Poobalan Naidoo, Babatope Kolawole, et al.. (2020). Management of adult patients with type 1 diabetes mellitus in Africa. Medicine. 99(25). e20553–e20553. 8 indexed citations
12.
Malek, Rachid, et al.. (2019). Diabetes and Ramadan: A multicenter study in Algerian population. Diabetes Research and Clinical Practice. 150. 322–330. 38 indexed citations
13.
14.
15.
16.
Home, Philip, Guillermo González-Gálvez, Rachid Malek, et al.. (2013). Short And Long-Term Cost-Effectiveness Of Starting Insulin Detemir In Insulin-Naïve People With Type-2 Diabetes. Value in Health. 16(3). A164–A164. 2 indexed citations
17.
Malek, Rachid, et al.. (2013). Short and Long-Term Cost-Effectiveness of Switching Therapy from Insulin Glargine to Insulin Detemir in People with Type 2 Diabetes. Value in Health. 16(7). A690–A690. 1 indexed citations
18.
Home, Philip, Rachid Malek, Guillermo González-Gálvez, et al.. (2013). Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes. Value in Health. 16(7). A690–A690. 1 indexed citations
19.
20.
Malek, Rachid, et al.. (2012). Influence of Retinopathy on Plasma Concentrations of total Homocysteine and other Biochemical Parameters in Algerian Patients with Type 2 Diabetes Mellitus. SHILAP Revista de lepidopterología. 23(1). 96–103. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miho Senda Breakdown of academic impact, for papers by Weigang Zhao Breakdown of academic impact, for papers by MK Garg Breakdown of academic impact, for papers by Thijs T. W. van Herpt Breakdown of academic impact, for papers by Fatheya Alawadi Breakdown of academic impact, for papers by Chidum E. Ezenwaka Breakdown of academic impact, for papers by Margaret Tiktin Breakdown of academic impact, for papers by Helen X. Gao Breakdown of academic impact, for papers by Jiemin Pan Breakdown of academic impact, for papers by Andreas Liebl
Rankless by CCL
2026